| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CUL1 UBR1 MIS18BP1 POLR2B ADNP2 LANCL1 VTA1 ADNP BIRC6 ARPC4 PTK2 RLF NAA35 URB1 G3BP1 MICAL2 XRN1 CCT8 DDX23 POLD3 HSPA1L GCN1 | 2.96e-09 | 1353 | 125 | 22 | 29467282 |
| Pubmed | 3.61e-07 | 418 | 125 | 11 | 34709266 | ||
| Pubmed | VTA1 ADNP BIRC6 GDI2 ARPC4 RIOX2 G3BP1 GLDC XRN1 POLD3 GCN1 MAD2L1 | 5.56e-07 | 534 | 125 | 12 | 35032548 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CUL1 TOPAZ1 POLR2B NEB NSUN7 KMT2C VPS13D PTPRB HP DDX23 MICAL3 | 1.95e-06 | 497 | 125 | 11 | 36774506 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | BRPF3 POP4 MIS18BP1 DDX42 ARPC4 ARPC2 ZNF341 CLK1 GLDC TTLL4 TET1 RARS2 POLD3 ARHGAP18 MAPK10 DSCC1 ARAP2 | 2.36e-06 | 1242 | 125 | 17 | 30973865 |
| Pubmed | CERK BRPF3 ZBTB33 POLR2B ADNP2 SRPK2 FOXA1 INTS10 ARHGAP4 NAA35 ZFHX4 NT5DC2 XRN1 RARS2 ARAP2 KNL1 | 2.67e-06 | 1116 | 125 | 16 | 31753913 | |
| Pubmed | CERK BRPF3 SHROOM3 TRIOBP XPO4 ADNP ARHGAP4 KMT2C ABCA5 TTLL4 TET1 | 3.54e-06 | 529 | 125 | 11 | 14621295 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18425142 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11754636 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18562603 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31740487 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30501637 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27257062 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24899686 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22089112 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16963053 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20598862 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 3.64e-05 | 344 | 125 | 8 | 30333137 | |
| Pubmed | CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. | 3.84e-05 | 3 | 125 | 2 | 21187447 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 26758421 | ||
| Pubmed | Autophagy has a key role in the pathophysiology of schizophrenia. | 3.84e-05 | 3 | 125 | 2 | 24365867 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23747948 | ||
| Pubmed | Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer. | 3.84e-05 | 3 | 125 | 2 | 25940797 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 10856220 | ||
| Pubmed | Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors. | 3.84e-05 | 3 | 125 | 2 | 12912913 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19733287 | ||
| Pubmed | Apoptotic cell-mediated immunoregulation of dendritic cells does not require iC3b opsonization. | 3.84e-05 | 3 | 125 | 2 | 18713972 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 20584999 | ||
| Pubmed | Loci associated with genomic damage levels in chronic kidney disease patients and controls. | 3.84e-05 | 3 | 125 | 2 | 32265040 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 17569795 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 24117111 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 15652490 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | POLR2B DDX42 SRPK2 GDI2 ARPC4 CLK1 CCT8 DDX23 HSPA1L GCN1 MAD2L1 | 5.64e-05 | 714 | 125 | 11 | 28302793 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CUL1 BZW2 POLR2B XPO4 SRPK2 ARPC4 PTK2 STRIP1 ARPC2 KMT2C G3BP1 DDX23 RARS2 GCN1 MAD2L1 | 6.03e-05 | 1284 | 125 | 15 | 17353931 |
| Pubmed | Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. | 7.65e-05 | 4 | 125 | 2 | 11717410 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 7539791 | ||
| Pubmed | Overexpression of Fbxo6 inactivates spindle checkpoint by interacting with Mad2 and BubR1. | 7.65e-05 | 4 | 125 | 2 | 30526252 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 18779337 | ||
| Pubmed | The MICAL proteins and rab1: a possible link to the cytoskeleton? | 7.65e-05 | 4 | 125 | 2 | 15694364 | |
| Pubmed | Intestinal reperfusion injury is mediated by IgM and complement. | 7.65e-05 | 4 | 125 | 2 | 10066708 | |
| Pubmed | αvβ5 Integrin/FAK/PGC-1α Pathway Confers Protective Effects on Retinal Pigment Epithelium. | 7.65e-05 | 4 | 125 | 2 | 26244551 | |
| Pubmed | Modulation of ceramide metabolism in mouse primary macrophages. | 7.65e-05 | 4 | 125 | 2 | 20637730 | |
| Pubmed | FBXO32, encoding a member of the SCF complex, is mutated in dilated cardiomyopathy. | 7.65e-05 | 4 | 125 | 2 | 26753747 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 28076779 | ||
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 7.65e-05 | 4 | 125 | 2 | 24440334 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 11278329 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 17681821 | ||
| Pubmed | A new standard nomenclature for proteins related to Apx and Shroom. | 7.65e-05 | 4 | 125 | 2 | 16615870 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 15676177 | ||
| Pubmed | 7.69e-05 | 493 | 125 | 9 | 15368895 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RAB22A VTA1 PBLD LCN2 NEB GDI2 ARPC4 STRIP1 ARPC2 VPS13D HP GLUL CCT8 | 7.84e-05 | 1016 | 125 | 13 | 19056867 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 7.93e-05 | 495 | 125 | 9 | 27705803 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 8.42e-05 | 287 | 125 | 7 | 36180891 | |
| Pubmed | BZW2 POLR2B TRIOBP XPO4 BIRC6 PTPRB ZFYVE9 MTMR2 UBR3 MICAL3 GCN1 MAD2L1 KNL1 | 1.08e-04 | 1049 | 125 | 13 | 27880917 | |
| Pubmed | 1.11e-04 | 300 | 125 | 7 | 28561026 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 23148219 | ||
| Pubmed | DNA demethylation fine-tunes IL-2 production during thymic regulatory T cell differentiation. | 1.27e-04 | 5 | 125 | 2 | 36880575 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 12844492 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 12110185 | ||
| Pubmed | Complement and microglia mediate early synapse loss in Alzheimer mouse models. | 1.27e-04 | 5 | 125 | 2 | 27033548 | |
| Pubmed | Interactions among subunits of human Arp2/3 complex: p20-Arc as the hub. | 1.27e-04 | 5 | 125 | 2 | 11162547 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 22000412 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 19695571 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 20400979 | ||
| Pubmed | Linkage of the gene for uncoupling protein to esterase-1,2 and haptoglobin in the rat. | 1.27e-04 | 5 | 125 | 2 | 8228167 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 12565863 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 11927607 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 35304452 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 16099106 | ||
| Pubmed | MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma. | 1.27e-04 | 5 | 125 | 2 | 26934001 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 26275994 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 33761330 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 21953030 | ||
| Pubmed | 1.51e-04 | 74 | 125 | 4 | 29795351 | ||
| Pubmed | Spermatogonia-dependent expression of testicular genes in mice. | 1.55e-04 | 29 | 125 | 3 | 12051830 | |
| Pubmed | 1.70e-04 | 225 | 125 | 6 | 12168954 | ||
| Pubmed | 1.72e-04 | 549 | 125 | 9 | 38280479 | ||
| Pubmed | DOCK2 CUL1 BZW2 DACH1 ADNP GDI2 RLF KMT2C G3BP1 ZBTB40 CCT8 DDX23 KNL1 | 1.76e-04 | 1103 | 125 | 13 | 34189442 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CUL1 ZBTB33 POLR2B BIRC6 GDI2 URB1 G3BP1 GLUL CCT8 DDX23 RARS2 POLD3 GCN1 MAD2L1 | 1.77e-04 | 1257 | 125 | 14 | 37317656 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.80e-04 | 552 | 125 | 9 | 10737800 | |
| Pubmed | 1.89e-04 | 31 | 125 | 3 | 25645918 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CUL1 POLR2B DDX42 LANCL1 ADNP GDI2 ARPC2 RIOX2 URB1 G3BP1 NT5DC2 ZC3HAV1L GLUL CCT8 GCN1 | 1.90e-04 | 1425 | 125 | 15 | 30948266 |
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 15879922 | ||
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 28077433 | ||
| Pubmed | FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle. | 1.90e-04 | 6 | 125 | 2 | 16714087 | |
| Pubmed | Genetic risk factors for placental abruption: a HuGE review and meta-analysis. | 1.90e-04 | 6 | 125 | 2 | 18277167 | |
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 25888260 | ||
| Pubmed | Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. | 1.90e-04 | 6 | 125 | 2 | 15531760 | |
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 17462990 | ||
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 10805755 | ||
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 28756234 | ||
| Pubmed | SHROOM3 TRIOBP SRPK2 ADNP GDI2 ARPC4 PTK2 STRIP1 ARPC2 G3BP1 GLUL CCT8 | 1.91e-04 | 963 | 125 | 12 | 28671696 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.12e-04 | 444 | 125 | 8 | 34795231 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.14e-04 | 235 | 125 | 6 | 30258100 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 2.16e-04 | 150 | 125 | 5 | 28242625 | |
| Pubmed | 2.18e-04 | 335 | 125 | 7 | 15741177 | ||
| Pubmed | 2.24e-04 | 237 | 125 | 6 | 29564676 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL1 BZW2 POLR2B VTA1 BIRC6 GDI2 ARPC4 ARPC2 G3BP1 GLUL MTMR2 CCT8 POLD3 HSPA1L GCN1 | 2.37e-04 | 1455 | 125 | 15 | 22863883 |
| Pubmed | DOCK2 LANCL1 NEB GDI2 ARPC4 G3BP1 NT5DC2 GLUL CCT8 HSPA1L GCN1 | 2.43e-04 | 844 | 125 | 11 | 25963833 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 2.46e-04 | 454 | 125 | 8 | 33226137 | |
| Interaction | ASXL3 interactions | 6.99e-06 | 165 | 121 | 8 | int:ASXL3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.37e-05 | 15 | 91 | 3 | 529 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 5.18e-04 | 7 | 91 | 2 | 785 | |
| GeneFamily | Actin related protein 2/3 complex | 8.82e-04 | 9 | 91 | 2 | 39 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 4.36e-07 | 199 | 123 | 9 | M9253 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_UP | 4.51e-06 | 198 | 123 | 8 | M5455 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | BRPF3 SGMS2 RAB22A LCN2 F5 NSUN7 RIOX2 TBC1D8 PHF20L1 TTLL4 GNB5 UBR3 C3 FBXO32 | 8.23e-06 | 726 | 123 | 14 | M4210 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | RAG1 SGMS2 MIS18BP1 DACH1 LCN2 F5 TBC1D8 CHST15 HP TET1 C3 CALCRL MAD2L1 KNL1 | 5.29e-08 | 395 | 120 | 14 | GSM538351_500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | RAG1 SGMS2 MIS18BP1 LCN2 F5 TBC1D8 CHST15 HP NT5DC2 TET1 C3 CALCRL KNL1 | 5.05e-07 | 405 | 120 | 13 | GSM538343_500 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | RAG1 MIS18BP1 LCN2 TBC1D8 CHST15 HP NT5DC2 TET1 C3 MAD2L1 KNL1 PLD4 | 2.09e-06 | 388 | 120 | 12 | GSM538352_500 |
| CoexpressionAtlas | B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3 | RAG1 MIS18BP1 LCN2 TBC1D8 CHST15 HP NT5DC2 TET1 C3 KNL1 PLD4 | 3.40e-06 | 337 | 120 | 11 | GSM777024_500 |
| CoexpressionAtlas | B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1 | RAG1 MIS18BP1 LCN2 HP NT5DC2 TET1 C3 CALCRL DSCC1 MAD2L1 KNL1 | 3.50e-06 | 338 | 120 | 11 | GSM538347_500 |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 3.60e-06 | 339 | 120 | 11 | GSM777027_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MIS18BP1 ZBTB20 RAB22A DDX42 XPO4 LCN2 BIRC6 RLF KMT2C VPS13D TET1 ZC3HAV1L GLUL FBXO32 CALCRL KNL1 | 9.72e-06 | 790 | 120 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SPATA7 UBR1 ZBTB20 ZBTB33 POLR2B ADNP GDI2 ZFYVE9 CLK1 TET1 UBR3 DSCC1 KNL1 MAP3K19 | 1.29e-05 | 629 | 120 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | SGMS2 MIS18BP1 DACH1 LCN2 F5 TBC1D8 HP NT5DC2 C3 MAD2L1 KNL1 | 1.49e-05 | 394 | 120 | 11 | GSM777030_500 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 2.71e-05 | 31 | 120 | 4 | gudmap_kidney_P0_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2 | MIS18BP1 DACH1 LCN2 ITGB5 HP NT5DC2 TET1 ZC3HAV1L CALCRL DSCC1 KNL1 | 2.79e-05 | 422 | 120 | 11 | GSM791124_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 4.16e-05 | 68 | 120 | 5 | GSM605875_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | MIS18BP1 ZBTB20 RAB22A DDX42 XPO4 LCN2 BIRC6 RLF KMT2C TET1 GLUL C3 FBXO32 CALCRL KNL1 | 4.52e-05 | 799 | 120 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_200 | 6.17e-05 | 38 | 120 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 POP4 MIS18BP1 SLC26A5 RLF ZFYVE9 PHF20L1 TET1 DSCC1 MAD2L1 CCDC40 | 7.25e-05 | 469 | 120 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 7.68e-05 | 391 | 120 | 10 | GSM854329_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 9.08e-05 | 399 | 120 | 10 | GSM538345_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 9.65e-05 | 402 | 120 | 10 | GSM854320_500 | |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Bone marrow, avg-2 | 1.01e-04 | 404 | 120 | 10 | GSM791129_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 1.16e-04 | 411 | 120 | 10 | GSM605872_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 1.21e-04 | 85 | 120 | 5 | GSM791143_100 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | RAG1 MIS18BP1 BZW2 LCN2 NT5DC2 TET1 ZC3HAV1L DSCC1 MAD2L1 KNL1 | 1.35e-04 | 419 | 120 | 10 | GSM538348_500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 1.44e-04 | 422 | 120 | 10 | GSM399442_500 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | MIS18BP1 DACH1 LCN2 SHROOM4 NT5DC2 TET1 ZC3HAV1L CALCRL MAD2L1 KNL1 | 1.46e-04 | 423 | 120 | 10 | GSM791126_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | MIS18BP1 ZBTB20 ADAMTS4 RAB22A XPO4 LCN2 BIRC6 RLF TET1 GLUL C3 FBXO32 CALCRL KNL1 | 1.65e-04 | 797 | 120 | 14 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 1.76e-04 | 92 | 120 | 5 | GSM791126_100 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 1.97e-04 | 51 | 120 | 4 | GSM777027_100 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1 | 3.38e-04 | 304 | 120 | 8 | GSM538354_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#2 | SHROOM3 NSUN7 TMEM132D NT5DC2 TET1 ENPP5 DSCC1 DHTKD1 MCOLN3 | 3.57e-04 | 387 | 120 | 9 | ratio_EB-blastocyst_vs_EB-fibro_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_200 | 3.95e-04 | 61 | 120 | 4 | gudmap_developingGonad_P2_epididymis_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_100 | 4.16e-04 | 26 | 120 | 3 | gudmap_developingGonad_e18.5_epididymis_100_k2 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 4.30e-04 | 397 | 120 | 9 | GSM791143_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_200 | 4.68e-04 | 6 | 120 | 2 | gudmap_kidney_P2_CapMes_Crym_k2_200 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 5.32e-04 | 409 | 120 | 9 | GSM476663_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 6.22e-04 | 418 | 120 | 9 | GSM538350_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.25e-04 | 121 | 120 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 6.32e-04 | 69 | 120 | 4 | GSM605872_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 6.32e-04 | 69 | 120 | 4 | GSM854329_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_100 | 6.53e-04 | 7 | 120 | 2 | gudmap_kidney_P3_CapMes_Crym_k4_100 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 6.65e-04 | 422 | 120 | 9 | GSM538355_500 | |
| CoexpressionAtlas | Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4 | 6.67e-04 | 70 | 120 | 4 | GSM605846_100 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 6.77e-04 | 423 | 120 | 9 | GSM399454_500 | |
| CoexpressionAtlas | Myeloid Cells, GN.UrAc.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3 | 7.04e-04 | 71 | 120 | 4 | GSM854312_100 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 7.05e-04 | 31 | 120 | 3 | gudmap_kidney_P1_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | MIS18BP1 RAB22A XPO4 SRPK2 BIRC6 RLF NAA35 CASD1 ZFHX4 CHST15 TET1 CALCRL MAPK10 | 7.11e-04 | 815 | 120 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | 7.48e-04 | 429 | 120 | 9 | gudmap_kidney_adult_Mesangium_Meis_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | 7.82e-04 | 73 | 120 | 4 | GSM538351_100 | |
| CoexpressionAtlas | Myeloid Cells, GN.Thio.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3 | 8.23e-04 | 74 | 120 | 4 | GSM854309_100 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.23e-04 | 74 | 120 | 4 | gudmap_kidney_P0_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 8.52e-04 | 437 | 120 | 9 | GSM605865_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.86e-04 | 532 | 120 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.99e-04 | 197 | 120 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_500 | 9.55e-04 | 77 | 120 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#5_top-relative-expression-ranked_500 | 9.91e-04 | 134 | 120 | 5 | gudmap_developingKidney_e11.5_metaneph mesench_500_k5 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | CTSF SGMS2 SHROOM3 ZBTB20 DACH1 LRRC42 GLDC NT5DC2 GLUL CALCRL HSPA1L | 1.01e-03 | 639 | 120 | 11 | gudmap_kidney_P0_CapMes_Crym_1000 |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 1.05e-03 | 79 | 120 | 4 | GSM538343_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_500 | 1.10e-03 | 36 | 120 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_500 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-08 | 193 | 124 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 169 | 124 | 7 | 1000eaf5158596b4898bedcc802b31db76b05a48 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 169 | 124 | 7 | 83b854fa8fd9017df8f9207d9ced260eee98e8c1 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 181 | 124 | 7 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 181 | 124 | 7 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 193 | 124 | 7 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 194 | 124 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.86e-06 | 149 | 124 | 6 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-06 | 157 | 124 | 6 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-06 | 165 | 124 | 6 | 3cdb921f5b9facf04f81995d5641ac14ef3dbb6f | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-06 | 167 | 124 | 6 | cfcd72292c733cdb18c92fdb61b68f6806d22c8c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-06 | 168 | 124 | 6 | c0ff30e2c47005514131a0866cf10a1c228128fc | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-06 | 170 | 124 | 6 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 9.71e-06 | 175 | 124 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 9.71e-06 | 175 | 124 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 177 | 124 | 6 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 180 | 124 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.18e-05 | 181 | 124 | 6 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 182 | 124 | 6 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 182 | 124 | 6 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-05 | 188 | 124 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-05 | 188 | 124 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-05 | 188 | 124 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.59e-05 | 191 | 124 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 192 | 124 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 193 | 124 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 193 | 124 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 193 | 124 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 193 | 124 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 194 | 124 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 195 | 124 | 6 | 2cb435dae2691e1250e26e59f9b8fb652a0c383e | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 195 | 124 | 6 | 217908cb53016a6cb51f1bc3fc752c8df650df71 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-05 | 196 | 124 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.90e-05 | 197 | 124 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.90e-05 | 197 | 124 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.95e-05 | 198 | 124 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 199 | 124 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 2.07e-05 | 200 | 124 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.07e-05 | 200 | 124 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-05 | 130 | 124 | 5 | 0f9d3e6297f48ae14d24ac997d8d3a94f337d4d4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.19e-05 | 130 | 124 | 5 | fc68a648161dd314d9ee6612fd039cb12171b8c6 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 143 | 124 | 5 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 143 | 124 | 5 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.11e-05 | 149 | 124 | 5 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.30e-05 | 150 | 124 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 154 | 124 | 5 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 154 | 124 | 5 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 156 | 124 | 5 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 156 | 124 | 5 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 156 | 124 | 5 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 156 | 124 | 5 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 156 | 124 | 5 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 156 | 124 | 5 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 158 | 124 | 5 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 158 | 124 | 5 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 158 | 124 | 5 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 158 | 124 | 5 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 8.30e-05 | 159 | 124 | 5 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 8.81e-05 | 161 | 124 | 5 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.07e-05 | 162 | 124 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-05 | 163 | 124 | 5 | 04152557aae230e9587fcc16cbabf1247cc5b419 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-05 | 163 | 124 | 5 | 0644eb8a66d4e944063125c423de66d2393388b1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.33e-05 | 163 | 124 | 5 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.61e-05 | 164 | 124 | 5 | cd0794f84dfd346807e2d803723718b7f22e9232 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.61e-05 | 164 | 124 | 5 | 12251a49fd4af32d4edb58046245548c260cf04b | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 164 | 124 | 5 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 165 | 124 | 5 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 167 | 124 | 5 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 167 | 124 | 5 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.08e-04 | 168 | 124 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 168 | 124 | 5 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 169 | 124 | 5 | 05b138511039f1255a5f647040b1b9bdf222bd52 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 169 | 124 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 169 | 124 | 5 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 169 | 124 | 5 | bf0a97f53d6e3f9ffeaeae0402b010c49a6cccb7 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 171 | 124 | 5 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | P15|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-04 | 171 | 124 | 5 | 155e7abd52b84d16146001f6ca49ca0c2294a823 | |
| ToppCell | droplet-Spleen-SPLEEN|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | d32731a56e113ff0ef7167b23959d69baf2068f9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 173 | 124 | 5 | 0451450605521fecb27a958628870d268adfb023 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 173 | 124 | 5 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-04 | 175 | 124 | 5 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.48e-04 | 25 | 122 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | brain glioma (is_marker_for) | 1.68e-04 | 5 | 122 | 2 | DOID:0060108 (is_marker_for) | |
| Disease | pulmonary hypertension (is_implicated_in) | 2.58e-04 | 30 | 122 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | sarcoma (is_implicated_in) | 4.67e-04 | 8 | 122 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | heel bone mineral density, urate measurement | 9.78e-04 | 182 | 122 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.28e-03 | 13 | 122 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | systemic scleroderma (is_marker_for) | 1.39e-03 | 53 | 122 | 3 | DOID:418 (is_marker_for) | |
| Disease | allergic disease (is_implicated_in) | 1.72e-03 | 15 | 122 | 2 | DOID:1205 (is_implicated_in) | |
| Disease | lung small cell carcinoma (is_marker_for) | 1.96e-03 | 16 | 122 | 2 | DOID:5409 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 2.04e-03 | 215 | 122 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | cyclic adenosine monophosphate measurement | 2.21e-03 | 17 | 122 | 2 | EFO_0010473 | |
| Disease | hearing loss | 2.72e-03 | 67 | 122 | 3 | EFO_0004238 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 3.07e-03 | 20 | 122 | 2 | DOID:2986 (is_marker_for) | |
| Disease | nucleotide measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0010513 | |
| Disease | Schizophrenia | 3.71e-03 | 883 | 122 | 10 | C0036341 | |
| Disease | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 3.71e-03 | 22 | 122 | 2 | EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798 | |
| Disease | triacylglycerol 48:3 measurement | 3.71e-03 | 22 | 122 | 2 | EFO_0010406 | |
| Disease | Down syndrome (is_marker_for) | 3.71e-03 | 22 | 122 | 2 | DOID:14250 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QMANYFSKSLVSKIF | 556 | A8MVM7 | |
| KQQMYTIAKFHFFTL | 841 | Q8WWZ7 | |
| AVANYIMKIHNFTSK | 476 | Q9H2P0 | |
| YQTVFKTIIKEMAAH | 356 | Q5W0A0 | |
| YDNIHFMKAFQKIVV | 351 | Q9Y6E2 | |
| HVDQQSISKSKMVKY | 56 | P0C6C1 | |
| KVNKHIDYSFQMSEQ | 16 | Q75V66 | |
| LGFKVNYHYMSQVKN | 4551 | Q9NR09 | |
| NFVNMIYKTLNIHVT | 231 | Q9H2U9 | |
| MVSISLKFYKELQAH | 56 | O15144 | |
| EKKLHNATNYFLMSL | 81 | P28335 | |
| TLSVVTMYHAKAKDQ | 1341 | P01024 | |
| MKYNAKDTIFHRAAV | 666 | Q9ULD4 | |
| KAGQSLQMEFLYHNK | 856 | Q8WZ64 | |
| KSSYYAKLNDHLNNM | 481 | Q96HY7 | |
| KIKLEAMSNYHASNN | 346 | Q9UI36 | |
| AALMIFDFYKQNKTT | 1856 | Q00975 | |
| ALMVNHYKVQLKFTC | 91 | A6H8M9 | |
| NFSNTLYYSMKKHVL | 161 | Q6IQ32 | |
| TLAFNTYVHFQGKMK | 266 | P01019 | |
| RKMAYQICKSVNFLH | 266 | P49759 | |
| LYTSKYLQKFMNAHN | 996 | P15918 | |
| YLQKFMNAHNALKTS | 1001 | P15918 | |
| SFMTKTVQYQNELHK | 41 | Q9UL26 | |
| SAAVLFHKIKNMNST | 86 | P30039 | |
| MLHNFLSEQKTISYA | 81 | Q6IEU7 | |
| AKKKSVAMHTNYLSA | 186 | O14775 | |
| EAHAKYKNQVVYSTM | 301 | Q9NVR2 | |
| HFMKLQADSNYLLSK | 1691 | P23467 | |
| MISFAHNVAAQGKYI | 336 | P50395 | |
| THYFVMTAKKQSLLD | 296 | Q7RTP6 | |
| SKQFVHSKSSQYRKM | 4751 | Q8NEZ4 | |
| FTTTIHKVNSMVAYK | 186 | Q13257 | |
| LKKIENQVAMSFYKH | 751 | Q6P0N0 | |
| RNANFKFTDHLKYVM | 286 | P00738 | |
| KQVDVSYIAKHYNMS | 26 | P53779 | |
| VAAVLYHKMNNEKQA | 116 | O43813 | |
| GKSFINYQFMSSHIK | 556 | Q86T24 | |
| TKQSAMAICQHFYKR | 151 | Q8TDD5 | |
| LTAMKAAFQSQYKSH | 696 | Q86XP3 | |
| VFKAADSKHTNMVDY | 566 | Q5JST6 | |
| NKSFSLDHMNIYDSK | 101 | Q9UJA9 | |
| KYLQAIMDSNAQSHK | 301 | Q13614 | |
| KMTKVFTHQGKVALY | 2006 | Q8NG31 | |
| KNALESYAFNMKSVV | 541 | P34931 | |
| TELQMALYYSQHAVK | 91 | H0YM25 | |
| VSQHKSALLDFYMKN | 216 | Q92616 | |
| HMNSSEKLQFYKEKA | 356 | Q9Y546 | |
| NFESGKHKYRQTVMF | 591 | Q9BUQ8 | |
| AVTKNHYMLYKNFTA | 336 | P18084 | |
| VNHSKFMVTEKAAYI | 426 | Q96BZ4 | |
| VSTNYNQHAMVFFKK | 131 | P80188 | |
| MSSSEQQHKLDFKAY | 406 | P55317 | |
| YLLTVMAAAAKAFKH | 241 | O75173 | |
| RANLFMKENKFYTHS | 386 | Q96PB1 | |
| LTKYSHSSMQNGVKV | 371 | Q9BVC3 | |
| QQHFSATLAYKKLMT | 701 | Q92608 | |
| EVYRVKKFQFTSKHM | 451 | Q8TCT0 | |
| LDVHKKYNALVMSAF | 371 | Q13616 | |
| YGQKEIHRKVMSQNF | 56 | Q13283 | |
| LQEHMTSNKTTKYFN | 636 | Q4G0X9 | |
| VKMASIFKNFVITYN | 181 | Q9UBX1 | |
| KNITQLSYQSHMALK | 611 | P32019 | |
| NVKYMQLKVESFTIH | 681 | P32019 | |
| KDMLNSKTKTQYFHQ | 66 | Q969P5 | |
| KVTHQAESNLYMKAV | 321 | Q16602 | |
| QQRKSEEFSTSHMKY | 186 | Q56UN5 | |
| THYFVMTAKKQSLLD | 296 | O94851 | |
| FHMRSKNSLQYSAKE | 896 | A8MW92 | |
| SSHLNKGIKQVYMSL | 6 | P15104 | |
| TMIYVTDKGQKKHFQ | 341 | Q5T160 | |
| MSNFLHLKYNEKSVS | 1 | Q9H628 | |
| MKGKVNVVVNFTYQH | 496 | Q14C87 | |
| DNFSNQIGKHYKKVM | 381 | P12259 | |
| KTVIQAIHKYAFMTS | 226 | Q86YW0 | |
| SMAKTLANKHGYQVD | 356 | P58743 | |
| QQQYEQLTHAMKFTK | 416 | Q8NE18 | |
| MLHNFLSEQKTISYA | 81 | Q8NGP8 | |
| SLQQEYKKQMLTAAH | 1011 | Q05397 | |
| YKKQMLTAAHALAVD | 1016 | Q05397 | |
| KQHKYTSIAEVQAQM | 471 | Q5VSL9 | |
| MKSVIYHALSQKEAN | 1 | O95707 | |
| AQEKMATNTVYVFAK | 196 | P30876 | |
| EQLQDYQHFVKMKST | 1916 | Q8TF72 | |
| YQHFVKMKSALIIEQ | 1451 | Q9ULL8 | |
| KMLVNFIVHKNTISY | 86 | Q8NGG5 | |
| FYSRQKHMKLIVAAD | 1701 | P14410 | |
| ASIHVYSIQKAMLKD | 96 | Q15054 | |
| YHSMANEKNLKVSSQ | 291 | Q8NHU3 | |
| HVVMQYNFDFSKLLK | 571 | O60287 | |
| FQIHTKDAVYTLSAM | 1856 | Q9H2D6 | |
| TAKKTYQAYHMESVN | 166 | P98171 | |
| YKFLKDTANHKNAMS | 791 | Q8NFU7 | |
| FLITNFHTEQMYKHK | 116 | P59998 | |
| HASNVKYTMHKVFQF | 481 | Q7LFX5 | |
| TYHKKSAFQVYMINL | 51 | Q9Y271 | |
| FKTMQKLQIHSQYHA | 1361 | Q86UP3 | |
| TYFQLKSHMTQHKNE | 456 | Q9BYN7 | |
| HYIAMFESSQNVLLK | 246 | Q9C0E2 | |
| FNSKYFSDLKQHMIL | 211 | Q9UID6 | |
| YVAASKHFQQAKMIL | 656 | Q5VZE5 | |
| VMSNLHSKENYDKYS | 31 | Q9HCQ7 | |
| KHNYSKEKVLQLTMF | 1151 | Q13129 | |
| MTKKYEHVDIQNFSS | 391 | A8MU46 | |
| MIKKKHLVAFYQEQS | 721 | Q8NDV3 | |
| HKNMIKSFYTASLLI | 111 | Q9NP79 | |
| KINQYNLKTFEMSHQ | 1116 | O95759 | |
| FVAMKVVKSAQHYTE | 106 | P78362 | |
| HLKYFVNMKISTDKS | 146 | Q8IZH2 | |
| QKNFIETHKLMYDNT | 1041 | Q8IWV7 | |
| HMAVHYNKILSAKAA | 51 | Q9P0W8 | |
| QKSLLMKIDAFHYVQ | 126 | Q9H857 | |
| AGTANTMHLLIKYQK | 506 | Q8N392 | |
| AQEKMVYIYHSLKNS | 386 | Q8IUF8 | |
| TFTAKQNYVKHMFVH | 586 | Q9HC78 | |
| FVKHMTVNVNKEQVY | 1651 | Q8N9V7 | |
| EMHVNNSVKYSKLKS | 626 | Q9UJ78 | |
| TKTFVQHYAFIMKTL | 416 | Q6ZT12 | |
| SEAFISIVHMYQKVK | 551 | Q9NYU1 | |
| YNSKFNLDMHQKVHT | 521 | Q9NZL3 | |
| LGNKFMHLTNYSVNK | 801 | Q14679 | |
| MHLTNYSVNKKNAEY | 806 | Q14679 | |
| KVADMALHYANKYNI | 296 | P50990 | |
| NSTGDLMKKNYLHNF | 536 | O95405 | |
| VHKMKAVYLALNQCS | 296 | Q13488 | |
| MTFTQASALAYHTKK | 871 | Q9NUA8 | |
| SVVNFQIISTYKHMK | 231 | Q96H79 | |
| MNTYTKRDHVFAKLN | 486 | Q5THJ4 | |
| NSYHSETNIVRYMKK | 526 | P23378 | |
| KQNAHTMNKHLYTID | 2226 | P20929 | |
| VLAKNNALTMSKHLY | 3681 | P20929 |